1. Neville BW, Damm DD, Allen CM, Chi AC. Oral and maxillofacial pathology. 4th ed. Elsevier Health Sciences: Missoouri, USA; 2015.
2. Ghazi N, Aali N, Shahrokhi VR, Mohajertehran F, Saghravanian N. Relative Expression of SOX2 and OCT4 in Oral Squamous Cell Carcinoma and Oral Epithelial Dysplasia. Rep Biochem Mol Biol. 2020;9(2):171-179. [
DOI:10.29252/rbmb.9.2.171] [
PMID] [
PMCID]
3. Shahabinejad M, Zare R, Mohajertehran F, Amouzad Mahdiraji A. Cytokeratins (CK7 and CK20) Genes Expression Association with Clinicopathological Indices in Oral Squamous Cell Carcinoma and Dysplastic Oral Epithelium. Rep Biochem Mol Biol. 2021;10(1):126-134. [
DOI:10.52547/rbmb.10.1.126] [
PMID] [
PMCID]
4. Mohtasham N, Shahabinejad M, Kafiroudi S, Mohajertehran F. Evaluation of the Altered Tissue Expression of HSP60 and HSP70 Genes in Oral and Cutaneous Lichen Planus Compared to Normal Healthy Tissues. Indian J Dermatol. 2021 Nov-Dec;66(6):591-597. [
DOI:10.4103/ijd.ijd_1060_20] [
PMID] [
PMCID]
5. Ni YH, Huang XF, Ding L, Wang ZY, Hu QG, Hou YY. Accumulation of CD208⁺ mature dendritic cells does not correlate with survival time in oral squamous cell carcinoma patients. J Oral Maxillofac Surg. 2014;72(11):2178-85. [
DOI:10.1016/j.joms.2014.04.038] [
PMID]
6. Lu J, Ma H, Lian S, Huang D, Lian M, Zhang Y, Huang J, Feng X. Clinical Significance and Prognostic Value of the Expression of LAMP3 in Oral Squamous Cell Carcinoma. Dis Markers. 2017;2017:1218254. [
DOI:10.1155/2017/1218254] [
PMID] [
PMCID]
7. Nishimura J, Tanaka H, Yamakoshi Y, Hiramatsu S, Tamura T, Toyokawa T, et al. Impact of tumor-infiltrating LAMP-3 dendritic cells on the prognosis of esophageal squamous cell carcinoma. Esophagus. 2019;16(4):333-344. [
DOI:10.1007/s10388-019-00669-w] [
PMID]
8. Santoro A, Majorana A, Roversi L, Gentili F, Marrelli S, Vermi W, et al. Recruitment of dendritic cells in oral lichen planus. J Pathol. 2005;205(4):426-34. [
DOI:10.1002/path.1699] [
PMID]
9. Qiu X, You Y, Huang J, Wang X, Zhu H, Wang Z. LAMP3 and TP53 overexpression predicts poor outcome in laryngeal squamous cell carcinoma. Int J Clin Exp Pathol. 2015;8(5):5519-27.
10. Nagelkerke A, Sweep FC, Stegeman H, Grénman R, Kaanders JH, Bussink J, Span PN. Hypoxic regulation of the PERK/ATF4/LAMP3-arm of the unfolded protein response in head and neck squamous cell carcinoma. Head Neck. 2015 Jun;37(6):896-905. [
DOI:10.1002/hed.23693] [
PMID]
11. Terkelsen T, Russo F, Gromov P, Haakensen VD, Brunak S, Gromova I et al. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration. Breast Cancer Res. 2020;22(1):73. [
DOI:10.1186/s13058-020-01295-6] [
PMID] [
PMCID]
12. Tanaka T, Warner BM, Odani T, Ji Y, Mo YQ, Nakamura H, et al. LAMP3 induces apoptosis and autoantigen release in Sjögren's syndrome patients. Sci Rep. 2020;10(1):15169. [
DOI:10.1038/s41598-020-71669-5] [
PMID] [
PMCID]
13. Kanao H, Enomoto T, Kimura T, Fujita M, Nakashima R, Ueda Y, et al. Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer. Cancer Res. 2005;65(19):8640-5. [
DOI:10.1158/0008-5472.CAN-04-4112] [
PMID]
14. Liao X, Chen Y, Liu D, Li F, Li X, Jia W. High Expression of LAMP3 Is a Novel Biomarker of Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma. Int J Mol Sci. 2015;16(8):17655-67. [
DOI:10.3390/ijms160817655] [
PMID] [
PMCID]
15. Alessandrini F, Pezzè L, Ciribilli Y. LAMPs: Shedding light on cancer biology. Semin Oncol. 2017;44(4):239-253. [
DOI:10.1053/j.seminoncol.2017.10.013] [
PMID]
16. Saitoh O, Wang WC, Lotan R, Fukuda M. Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials. J Biol Chem. 1992;267(8):5700-11. [
DOI:10.1016/S0021-9258(18)42823-2] [
PMID]
17. Lu J, Ma H, Lian S, Huang D, Lian M, Zhang Y, et al. Clinical Significance and Prognostic Value of the Expression of LAMP3 in Oral Squamous Cell Carcinoma. Dis Markers. 2017;2017:1218254. [
DOI:10.1155/2017/1218254] [
PMID] [
PMCID]
18. Sun R, Wang X, Zhu H, Mei H, Wang W, Zhang S, Huang J. Prognostic value of LAMP3 and TP53 overexpression in benign and malignant gastrointestinal tissues. Oncotarget. 2014;5(23):12398-409. [
DOI:10.18632/oncotarget.2643] [
PMID] [
PMCID]
19. Nagelkerke A, Mujcic H, Bussink J, Wouters BG, van Laarhoven HW, Sweep FC, Span PN. Hypoxic regulation and prognostic value of LAMP3 expression in breast cancer. Cancer. 2011;117(16):3670-81. [
DOI:10.1002/cncr.25938] [
PMID]
20. Nagelkerke A, Sieuwerts AM, Bussink J, Sweep FC, Look MP, Foekens JA, et al. LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy. Endocr Relat Cancer. 2014;21(1):101-12. [
DOI:10.1530/ERC-13-0183] [
PMID]